Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Giving capecitabine after surgery may kill any tumor cells that remain after surgery.
Sometimes, after surgery, the tumor may not need more treatment until it progresses. In this
case, observation may be sufficient. It is not yet known whether capecitabine is more
effective than observation in treating biliary tract cancer.
PURPOSE: This randomized phase III trial is studying capecitabine to see how well it works
compared with observation in treating patients with biliary tract cancer.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust